Showing posts with label Sun Pharmaceutical. Show all posts
Showing posts with label Sun Pharmaceutical. Show all posts

Wednesday, August 13, 2014

India Outlines Plan to Boost Inspections of Drug Facilities - Pharmalot - WSJ

Updated October 7, 2023

The original link broke.

You might also be interested in:

---  the original post follows below  ---

Read the full article: India Outlines Plan to Boost Inspections of Drug Facilities - Pharmalot - WSJ:

"Last year, the FDA conducted 111 inspections in India, up from 98 in 2011 and 59 in 2009, and has issued warning letters to several Indian drug makers. Significantly, the FDA also issued 21 so-called import alerts that allow the FDA to ban products from entering the U.S.

One widely known example is Ranbaxy Laboratories [500359.BY +1.16%], which is prevented from sending products from four of its plants in India and is also operating under a consent decree that requires improvements before the ban can be lifted. Sun Pharmaceuticals [524715.BY +1.46%] recently agreed to buy Ranbaxy for $3.2 billion"

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 


Monday, April 7, 2014

Sun Pharmaceutical to Buy Ranbaxy in $3.2 Billion Deal - WSJ.com


Sun Pharmaceutical to Buy Ranbaxy in $3.2 Billion Deal - WSJ.com:

"The deal would make Sun Pharma the largest pharmaceutical company in India and the fifth-largest generic drug company in the world. But it would also saddle the Mumbai-based company with the chore of fixing up Ranbaxy's operations and ending restrictions on its U.S. sales.

Before curbs imposed by the U.S. Food and Drug Administration, Ranbaxy earned about 40% of its revenue from the American market. Now, only one Ranbaxy plant, located in the U.S., is producing drugs for U.S. consumption."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

From SkillsPlus International Inc.